Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer

BACKGROUND: Tamoxifen is the cornerstone of adjuvant therapy for hormone receptor-positive breast cancer. Despite its efficacy, limited drug sensitivity and endocrine resistance remain the important clinical challenges. The main objective of this study was to investigate fatostatin, which was found...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Drug Des Devel Ther
Main Authors: Liu, Ying, Zhang, Ning, Zhang, Hanwen, Wang, Lijuan, Duan, Yi, Wang, Xiaolong, Chen, Tong, Liang, Yiran, Li, Yaming, Song, Xiaojin, Li, Chen, Han, Dianwen, Chen, Bing, Zhao, Wenjing, Yang, Qifeng
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2020
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7457819/
https://ncbi.nlm.nih.gov/pubmed/32921987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S253876
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker